Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  dexrazoxane hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 48 for your search:
Start Over
Phase II/III Chemotherapy with ICRF-187 for Disseminated Colorectal Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCT-1380
Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 0 to 21
Sponsor: NCI, Other
Protocol IDs: 9404, U10CA030969, POG-9404, CDR0000064664, NCT01230983
Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: 9426, POG-9426, CCG-P9426, CDR0000065013, COG-9426, NCT00002827
Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: 9425, COG-9425, CDR0000065359, P9425, POG-9425, NCT00005578
Combination Chemotherapy and Radiation Therapy in Treating Children With Acute Lymphoblastic Leukemia
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 1 to 17
Sponsor: NCI, Other
Protocol IDs: CDR0000066202, DFCI-95001, DFCI-FDR001197, NCI-G99-1651, NCT00004034
Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 30 and under
Sponsor: NCI, Other
Protocol IDs: P9754, COG-P9754, POG-P9754, CCG-P9754, CDR0000067129, NCT00003937
Phase III Pilot Randomized Study of Filgrastim-SD/01 Versus Filgrastim (G-CSF) With Concurrent Chemotherapy in Patients With Newly Diagnosed Sarcoma (Closed to Accrual as of 5/26/2009)
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 25 and under at diagnosis
Sponsor: NCI
Protocol IDs: NCI-00-C-0092, AMGEN-20000124, NCT00020137
Phase III Randomized Trial of Cardioprotection with ICRF-187 in Patients with Advanced Breast Cancer Treated with FAC (5-FU/ADR/CTX) (Summary Last Modified 06/97)
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NYU-8305, NCI-T83-1038D, T83-1038
Phase III Randomized Trial of FAC (5-FU/ADR/CTX) with vs without ICRF-187 for Cardioprotection in Patients with Advanced Breast Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: DUT-BR-1, NCI-T85-0009Q, T85-0009
Phase III Randomized Study of CAF (CTX/DOX/5-FU) with vs without Cardioprotection with ADR-529 in Women with Locally Advanced or Metastatic Carcinoma of the Breast
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: AECM-8710267, NCI-V88-0363
Phase III Randomized Comparison of Cardioprotection with ADR-529 vs No Cardioprotection in Women Receiving Combination Chemotherapy with CAF (CTX/ADR/5-FU) for Advanced Breast Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: GUMC-20989, NCI-V89-0278
Phase III Randomized Comparison of Cardioprotection with ADR-529 vs No Cardioprotection in Women Receiving Combination Chemotherapy with CAF (CTX/ADR/5-FU) for Advanced Breast Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: YALE-HIC-4660, NCI-V88-0378
Phase III Randomized Study of ICRF-187 Cardioprotection in Patients Treated with ADR for Pediatric Sarcomas
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 25 and under
Sponsor: NCI
Protocol IDs: NCI-89-C-07, NCI-T88-0200N, T88-0200
Phase III Double-Blind Randomized Trial of Cardioprotection with ADR-529 vs Placebo in Patients Treated with CAV (CTX/ADR/VCR) for Extensive Small Cell Lung Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: TCSC-ADR-529/LUNG, NCI-V89-0172
Phase III Randomized Comparison of Cardioprotection with ADR-529 vs No Cardioprotection in Women Receiving Combination Chemotherapy with CAF (CTX/DOX/5-FU) for Advanced Breast Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: TCSC-ADR-529/BREAST, NCI-V89-0171
Treatment of Acute Lymphoblastic Leukemia in Children
Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 17
Sponsor: NCI, Other
Protocol IDs: 05-001 / CDR0000513019, P01CA068484, P30CA006516, DFCI-05001, NCT00400946
A Study of IMC-3G3 in Soft Tissue Sarcoma
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 14055, I5B-IE-JGDG, CP15-0806, NCT01185964
A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents
Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: KDX1101, NCT01596088
Phase II Study of High-Dose Doxorubicin with Dexrazoxane Cardioprotection and GM-CSF for Advanced Malignant Mesothelioma (Summary Last Modified 09/97)
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: any age
Sponsor: NCI
Protocol IDs: CLB-9631, CALGB-9631
Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 25 and under
Sponsor: NCI
Protocol IDs: CDR0000067263, NCI-99-C-0125I, NCT00019864
Phase II Chemotherapy with ICRF-187 for Disseminated Adenocarcinoma of the Colon and Rectum
Phase: Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: WSU-C-36480
Phase II Comparison of CACP/VP-16/MeGAG vs ICRF-187 for Stage III non-Small Cell Lung Cancer Using Randomized Crossover Design
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 72
Sponsor:
Protocol IDs: UMCT-1680, UMCT-1680A
Phase II Master Protocol Chemotherapy with New Agents for Metastatic or Recurrent Colorectal Cancer --- ATDA vs ICRF-187 vs SPG and CHIP vs CBDCA
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-4282
Start Over